Autoimmune hepatitis

[1]  C. Efe,et al.  Acute autoimmune hepatitis , 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

[2]  M. Hussain,et al.  Autoantigen‐specific regulatory T cells, a potential tool for immune‐tolerance reconstitution in type‐2 autoimmune hepatitis , 2011, Hepatology.

[3]  R. Gish,et al.  Development of Hepatocellular Carcinoma in Autoimmune Hepatitis Patients: A Case Series , 2011, Digestive Diseases and Sciences.

[4]  M. Manns,et al.  Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. , 2010, Gastroenterology.

[5]  M. Hussain,et al.  A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis , 2010, Hepatology.

[6]  D. Adams,et al.  Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management , 2010, Hepatology international.

[7]  Xiong Ma.  [The diagnosis and treatment of autoimmune hepatitis]. , 2010, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[8]  B. Preston,et al.  Case Series , 2010, Toxicologic pathology.

[9]  D. Vergani,et al.  Autoantibodies and their antigens in autoimmune hepatitis. , 2009, Seminars in liver disease.

[10]  T. Steitz,et al.  The Human SepSecS-tRNASec Complex Reveals the Mechanism of Selenocysteine Formation , 2009, Science.

[11]  G. Mieli-Vergani,et al.  Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up. , 2009, Journal of hepatology.

[12]  F. Carrilho,et al.  Follow-up of Pregnant Women With Autoimmune Hepatitis: The Disease Behavior Along With Maternal and Fetal Outcomes , 2009, Journal of clinical gastroenterology.

[13]  Thomas Korn,et al.  IL-17 and Th17 Cells. , 2009, Annual review of immunology.

[14]  I. N. Crispe,et al.  The liver as a lymphoid organ. , 2009, Annual review of immunology.

[15]  A. Bergquist,et al.  Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients. , 2009, Journal of hepatology.

[16]  D. Vergani,et al.  Immunoglobulin on the surface of isolated hepatocytes is associated with antibody-dependent cell-mediated cytotoxicity and liver damage. , 2008, Liver.

[17]  P. Galle,et al.  Mycophenolate Mofetil as Second Line Therapy in Autoimmune Hepatitis? , 2008, The American Journal of Gastroenterology.

[18]  Z. Kuloğlu,et al.  Complete regression of cirrhosis after immunosuppressive treatment in autoimmune hepatitis , 2008, Pediatrics international : official journal of the Japan Pediatric Society.

[19]  Stefan Lüth,et al.  Serologic Markers Compared With Liver Biopsy for Monitoring Disease Activity in Autoimmune Hepatitis , 2008, Journal of clinical gastroenterology.

[20]  G. Mieli-Vergani,et al.  Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow‐up and screening , 2008, Hepatology.

[21]  D. Vergani,et al.  Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis , 2008, Hepatology.

[22]  A. Lohse,et al.  De novo autoimmune hepatitis after liver transplantation , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[23]  M. Hussain,et al.  Cytochrome P450IID6‐specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2 , 2007, Hepatology.

[24]  D. Vergani,et al.  [25] IDENTIFICATION OF HLA-DR3 RESTRICTED CD4 T-CELL EPITOPES ON SOLUBLE LIVER ANTIGEN IN AUTOIMMUNE HEPATITIS TYPE 1 , 2007 .

[25]  Y. Hiasa,et al.  Recurrence of autoimmune hepatitis after liver transplantation without elevation of alanine aminotransferase. , 2007, World journal of gastroenterology.

[26]  F. Alvarez,et al.  Follow-up of Children With Autoimmune Hepatitis Treated With Cyclosporine , 2006, Journal of pediatric gastroenterology and nutrition.

[27]  J. Schmeidler,et al.  Prospective Analysis of Nonadherence in Autoimmune Hepatitis: A Common Problem , 2006, Journal of pediatric gastroenterology and nutrition.

[28]  K. Murphy,et al.  Th17: an effector CD4 T cell lineage with regulatory T cell ties. , 2006, Immunity.

[29]  M. Hussain,et al.  Functional Study of CD4+CD25+ Regulatory T Cells in Health and Autoimmune Hepatitis1 , 2006, The Journal of Immunology.

[30]  M. Hussain,et al.  Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. , 2006, Gastroenterology.

[31]  K. Waki,et al.  Intravenous methylprednisolone pulse therapy for children with autoimmune hepatitis. , 2006, Hepatology research : the official journal of the Japan Society of Hepatology.

[32]  C. Anasetti,et al.  Antigen‐dependent suppression of alloresponses by Foxp3‐induced regulatory T cells in transplantation , 2005, European journal of immunology.

[33]  D. Vergani,et al.  Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. , 2005, Journal of autoimmunity.

[34]  L. Espinoza,et al.  Autoimmune hepatitis and pregnancy: a rheumatologist's dilemma. , 2005, Seminars in arthritis and rheumatism.

[35]  N. Kerkar,et al.  Rapamycin Successfully Treats Post‐Transplant Autoimmune Hepatitis , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[36]  A. Brunnberg,et al.  Clinical features and biochemical data of Caucasian children at diagnosis of autoimmune hepatitis. , 2005, Journal of autoimmunity.

[37]  R. Schreiber,et al.  Diagnosing autoimmune hepatitis in children: is the International Autoimmune Hepatitis Group scoring system useful? , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[38]  M. Manns,et al.  Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. , 2004, Journal of hepatology.

[39]  D. Vergani,et al.  Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. , 2004, Journal of hepatology.

[40]  F. Chiodo,et al.  Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type. , 2004, QJM : monthly journal of the Association of Physicians.

[41]  M. Herrath.  Faculty Opinions recommendation of CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. , 2004 .

[42]  S. Devlin,et al.  Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy. , 2004, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[43]  P. Donaldson.  Genetics of liver disease: immunogenetics and disease pathogenesis , 2004, Gut.

[44]  M. Salmon,et al.  The peripheral generation of CD4+ CD25+ regulatory T cells , 2003, Immunology.

[45]  D. Samuel,et al.  A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence , 2003, Gut.

[46]  P. Donaldson.  Genetics in Autoimmune Hepatitis , 2002, Seminars in liver disease.

[47]  Mark George Thomas,et al.  Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease , 2002, Hepatology.

[48]  A. Lohse,et al.  Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis , 2002, American Journal of Gastroenterology.

[49]  A. Granito,et al.  Smooth Muscle Antibodies and Type 1 Autoimmune Hepatitis , 2002, Autoimmunity.

[50]  D. Vergani,et al.  Organ and Non-organ Specific Autoantibody Titres and IgG Levels as Markers of Disease Activity: A Longitudinal Study in Childhood Autoimmune Liver Disease , 2002, Autoimmunity.

[51]  E. Shevach,et al.  Control of T‐cell activation by CD4+ CD25+ suppressor T cells , 2001, Immunological reviews.

[52]  R. Ciubotariu,et al.  CD8+CD28− T suppressor cells and the induction of antigen‐specific, antigen‐presenting cell‐mediated suppression of Th reactivity , 2001, Immunological reviews.

[53]  D. Vergani,et al.  Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity. , 2001, Current molecular medicine.

[54]  G. Gerken,et al.  Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience. , 2001, Zeitschrift fur Gastroenterologie.

[55]  D. Vergani,et al.  Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: A 16‐year prospective study , 2001, Hepatology.

[56]  M. Heneghan,et al.  Management and outcome of pregnancy in autoimmune hepatitis , 2001, Gut.

[57]  J. McHutchison,et al.  LKM-positive autoimmune hepatitis in the western United States: a case series , 2000, American Journal of Gastroenterology.

[58]  P. D. James,et al.  Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine. , 2000, Journal of hepatology.

[59]  A. Czaja,et al.  Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype‐1 autoimmune hepatitis , 2000, Clinical and experimental immunology.

[60]  J. Herkel,et al.  Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis , 2000, The Lancet.

[61]  P. Donaldson,et al.  Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis , 2000, Immunological reviews.

[62]  M. Manns,et al.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. , 1999, Journal of hepatology.

[63]  E. Elias,et al.  Recurrence of autoimmune hepatitis after liver transplantation. , 1999, Transplantation.

[64]  J. Girardet,et al.  Efficacy of cyclosporin A in children with type 2 autoimmune hepatitis. , 1999, The Journal of pediatrics.

[65]  F. Alvarez,et al.  Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. , 1999, Gastroenterology.

[66]  F. Alvarez,et al.  Short-term cyclosporine induces a remission of autoimmune hepatitis in children. , 1999, Journal of hepatology.

[67]  E. Concia,et al.  Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance , 1997, The Lancet.

[68]  J. Koziol,et al.  Range of antinuclear antibodies in "healthy" individuals. , 1997, Arthritis and rheumatism.

[69]  A. Czaja,et al.  Histological findings in chronic hepatitis C with autoimmune features , 1997, Hepatology.

[70]  D. Vergani,et al.  Autoimmune hepatitis in childhood: A 20‐year experience , 1997, Hepatology.

[71]  T. Therneau,et al.  Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. , 1996, Gastroenterology.

[72]  R. Williams,et al.  Azathioprine for long-term maintenance of remission in autoimmune hepatitis. , 1995, The New England journal of medicine.

[73]  A. Burroughs,et al.  Azathioprine-induced myelosuppression due to thiopurine methyltransferase deficiency in a patient with autoimmune hepatitis. , 1995, Journal of hepatology.

[74]  L. Fainboim,et al.  Chronic active autoimmune hepatitis in children. Strong association with a particular HLA-DR6 (DRB1*1301) haplotype. , 1994, Human immunology.

[75]  D. Vergani,et al.  Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis. , 1992, Archives of disease in childhood.

[76]  M. Manns,et al.  Liver‐infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro , 1992, Clinical and experimental immunology.

[77]  K. Sullivan,et al.  LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. , 1991, The Journal of clinical investigation.

[78]  M. Manns,et al.  Clonal analysis of liver‐infiltrating T cells in patients with LKM‐1 antibody‐positive autoimmune chronic active hepatitis , 1991, Clinical and experimental immunology.

[79]  D. Vergani,et al.  T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis , 1990, The Lancet.

[80]  R. Weinshilboum,et al.  Pharmacogenetics of acute azathioprine toxicity: Relationship to thiopurine methyltransferase genetic polymorphism , 1989, Clinical pharmacology and therapeutics.

[81]  Kenneth K Wang,et al.  Extrahepatic malignancy following long‐term immunosuppressive therapy of severe hepatitis B surface antigen‐negative chronic active hepatitis , 1989, Hepatology.

[82]  J. Bredfeldt,et al.  Autoimmune Chronic Active Hepatitis Masquerading as Acute Hepatitis , 1989, Journal of clinical gastroenterology.

[83]  O. Bernard,et al.  Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily , 1988, The Journal of experimental medicine.

[84]  M. Manns,et al.  CHARACTERISATION OF A NEW SUBGROUP OF AUTOIMMUNE CHRONIC ACTIVE HEPATITIS BY AUTOANTIBODIES AGAINST A SOLUBLE LIVER ANTIGEN , 1987, The Lancet.

[85]  Roger Williams,et al.  ANTIGEN SPECIFIC SUPPRESSOR CELL FUNCTION IN AUTOIMMUNE CHRONIC ACTIVE HEPATITIS , 1984, The Lancet.

[86]  G. Alexander,et al.  Effect of corticosteroids on suppressor-cell activity in "autoimmune" and viral chronic active hepatitis. , 1982, The New England journal of medicine.

[87]  S. Pocock,et al.  Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis. , 1980, Gut.

[88]  D. Vergani,et al.  Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis. , 1979, Clinical and experimental immunology.

[89]  A. Eddleston,et al.  Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. , 1978, The New England journal of medicine.

[90]  D. Doniach,et al.  Classification of smooth muscle autoantibodies detected by immunofluorescence. , 1976, Journal of clinical pathology.

[91]  R. Stern,et al.  Controlled trial of prednisone and azathioprine in active chronic hepatitis. , 1973, Lancet.

[92]  L. Elveback,et al.  Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. , 1972, Gastroenterology.

[93]  S. Sherlock,et al.  Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. , 1971, The Quarterly journal of medicine.

[94]  Kenn Nesbitt,et al.  A Common Problem , 1963, Social Service Review.

[95]  M. Hussain,et al.  AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Vigorous Activation of Monocytes in Juvenile Autoimmune Liver Disease Escapes the Control of Regulatory T-Cells , 2009 .

[96]  A. Czaja.  Safety issues in the management of autoimmune hepatitis. , 2008, Expert opinion on drug safety.

[97]  K. Boberg,et al.  Simplified criteria for the diagnosis of autoimmune hepatitis , 2008, Hepatology.

[98]  B. Portmann,et al.  Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis. , 2008, Journal of hepatology.

[99]  G. Galbraith.  A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage , 2008 .

[100]  K. Boberg,et al.  Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. , 1998, Scandinavian journal of gastroenterology.

[101]  D. V. van Thiel,et al.  Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. , 1995, The American journal of gastroenterology.

[102]  D. Vergani,et al.  Preferential activation of helper/inducer T lymphocytes in autoimmune chronic active hepatitis. , 1987, Clinical and experimental immunology.

[103]  D. Vergani,et al.  Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders. , 1986, Journal of hepatology.

[104]  P. Donaldson,et al.  HLA A1-B8-DR3 and suppressor cell function in first-degree relatives of patients with autoimmune chronic active hepatitis. , 1985, Journal of hepatology.

[105]  J. Ludwig,et al.  Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology. , 1983, Gastroenterology.